Research powered investment banking
Home
Research
Companies
Find Alpha
Themes
Top Picks
Premium
Transactions
Events
Redeye
At a Glance
Our Culture
Investor Services
Corporate Broking
Certified Adviser
Corporate Finance
Newsroom
The Team
Careers
FAQ
Governance
Members network
Community
sign in
Home
research
Companies
Find Alpha
Themes
Top Picks
Transactions
Events
redeye
About
At a Glance
Our Culture
Investor Services
Corporate Broking
Certified Adviser
Corporate Finance
Newsroom
The Team
Careers
FAQ
Governance
Community
Company overview

Christian Berner: Orderingång talar för starkt andra halvår

Redeye Research Update timeStamp 2019/08/22

Sedan vår föregående uppdatering har Christian Berner fallit med nästan 20%. Oron för en försvagad konjunktur har visserligen ökat men samtidigt har Q2-rapporten stärkt utsikterna för andra halvåret. Därtill ser ledningen ett fortsatt starkt efterfrågeläge. Aktien värderas till cirka 8x EBIT på våra prognoser för 2019, vilket vi – trots att vi räknar med fallande vinst under 2020 – tycker är för defensivt. Vårt Base case kvarstår på 27,50 SEK, innebärande en uppsida från nuvarande nivåer om cirka 15%.

Download research report

Fredrik Nilsson

Equity Analyst

Henrik Alveskog

Equity Analyst

Does Christian Berner Tech Trade have great people behind it? Find out now:
Visit Stock Insight
Tagged companies
  • Office
  • Mäster Samuelsgatan 42, 10th floor
  • Box 7141, 103 87
  • Stockholm, Sweden
  • info@redeye.se
  • +46 (0)8 545 013 30
  • Services
  • Home
  • Research
  • Transactions
  • Events
  • Redeye
  • Community
  • Members Home
  • Premium
  • Legal
  • Terms and conditions (Swedish)
  • Terms of membership (Swedish)
  • Terms and conditions - Advisory (Swedish)
  • Terms and conditions - Advisory (English)
  • Integrity Policy (Swedish)
  • Disclaimer (Swedish)
  • Governance
  • Follow
  • Twitter
  • Facebook
  • LinkedIn
  • Redeye
  • At a Glance
  • Our Culture
  • Investor Services
  • Corporate Broking
  • Corporate Finance
  • Newsroom
  • The Team
  • Careers
  • FAQ

© All rights reserved. Redeye AB is authorised and regulated by the Swedish Financial Supervisory Authority, Finansinspektionen. 2017

You need to be a Redeye member to access this content

Become a member to:

  • Access all our extensive research on 100+ Nordic Tech and Life Science companies
  • Make smarter investment decisions with the guidance of our experienced analysts
  • Receive exciting offers to participate in IPO’s and other transactions

    By clicking "Sign up" you indicate that you read and agree to our Terms & Conditions

    I already have an account and want to sign in